No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VTR Ventas Inc
- 48.470
- +0.100+0.21%
Close May 22 16:00 ET
19.62BMarket Cap-269277P/E (TTM)
48.670High48.210Low1.53MVolume48.240Open48.370Pre Close74.02MTurnover0.38%Turnover RatioLossP/E (Static)404.77MShares50.08352wk High2.09P/B19.52BFloat Cap38.58052wk Low1.80Dividend TTM402.68MShs Float61.550Historical High3.71%Div YieldTTM0.95%Amplitude0.690Historical Low48.450Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 65579.0 Shares on Buy Side
Express News | Ventas Inc : BMO Raises Target Price to $53 From $51
BMO Capital Adjusts Ventas Price Target to $53 From $51
Ventas (VTR) has an average rating of outperform and price targets ranging from $46 to $69, according to analysts polled by Capital IQ. Price: 48.80, Change: -0.11, Percent Change: -0.22
Real Estate Stocks Continue to Surge as Soft Inflation Reports Fuel Rate Cut Hopes
Insider Sale: Director Walter Rakowich Sells Shares of Ventas Inc (VTR)
Ventas Inc(VTR.US) Director Sells US$103.81K in Common Stock
$Ventas Inc(VTR.US)$ Director RAKOWICH WALTER C sold 2,145 shares of common stock on May 15, 2024 at an average price of $48.398 for a total value of $103.81K.Source: Announcement What is statement of
Comments
Analyst Connor Siversky predicts OHI and NHI's rent coverage will increase due to improving portfolio metrics. However, he doubts VTR's senior housing portfolio improvement will offset high leverage and limited investment opportunities. He also suggests OHI's dividend will be covered in late 2024, and NHI is set to drive growth with a strong liquidity profile.
Omega Healthcare, National Health Investors Upgraded to Overweight at Wells Fargo 1
follow for daily top watchlist ⭐️
$Apyx Medical(APYX.US$ $Addentax(ATXG.US$ $Axsome Therapeutics(AXSM.US$ $BioXcel Therapeutics(BTAI.US$ $Baudax Bio(BXRX.US$ $CymaBay Therapeutics(CBAY.US$ $CorMedix(CRMD.US$ $Marriott International(MAR.US$ $Microvision(MVIS.US$ $Renalytix(RNLX.US$ $State Street(STT.US$ $Treehouse Foods(THS.US$ $Targa Resources(TRGP.US$ $VBI Vaccines(VBIV.US$ $Ventas Inc(VTR.US$
$Apyx Medical(APYX.US$ $Addentax(ATXG.US$ $Axsome Therapeutics(AXSM.US$ $BioXcel Therapeutics(BTAI.US$ $Baudax Bio(BXRX.US$ $CymaBay Therapeutics(CBAY.US$ $CorMedix(CRMD.US$ $Marriott International(MAR.US$ $Microvision(MVIS.US$ $Renalytix(RNLX.US$ $State Street(STT.US$ $Treehouse Foods(THS.US$ $Targa Resources(TRGP.US$ $VBI Vaccines(VBIV.US$ $Ventas Inc(VTR.US$
1
$Affirm Holdings(AFRM.US$ initiated at neutral by Compass Point, announced target price at $15.00.
$SoFi Technologies(SOFI.US$ initiated at sell by Compass Point, announced targe price at $5.00.
$Evotec(EVO.US$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$Principal Financial(PFG.US$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
$SoFi Technologies(SOFI.US$ initiated at sell by Compass Point, announced targe price at $5.00.
$Evotec(EVO.US$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$Principal Financial(PFG.US$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
15
Upgrades
• $Advanced Micro Devices(AMD.US$ : Northland Capital Upgrades to Outperform from Market Perform - PT $95
• $Bunge(BG.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $140)
• $Brookfield Infrastructure Partners LP(BIP.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $49.50
• $Banco Santander Chile(BSAC.US$ : UBS Upgrades to Neutral from Sell - PT $18 (from $17)
• $Crown Castle(CCI.US$ : Jefferi...
• $Advanced Micro Devices(AMD.US$ : Northland Capital Upgrades to Outperform from Market Perform - PT $95
• $Bunge(BG.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $140)
• $Brookfield Infrastructure Partners LP(BIP.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $49.50
• $Banco Santander Chile(BSAC.US$ : UBS Upgrades to Neutral from Sell - PT $18 (from $17)
• $Crown Castle(CCI.US$ : Jefferi...
18
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
